Healthy Extracts Inc. reported a revenue increase of 45% for the fiscal year ending December 31, 2025, generating $4.5 million compared to $3.1 million in 2024. Despite this growth, the company continues to face financial challenges, posting a net loss of $881,119, slightly higher than the previous year's loss of $840,671. The increase in revenue was accompanied by a significant rise in costs, with the cost of revenue climbing 74% to $2.1 million, leading to a gross profit of $2.4 million, up 27% from the prior year.
The company's operational expenses also surged, reaching $3.4 million, a 108% increase from $2.1 million in 2024. This rise was primarily attributed to higher advertising costs and stock-based compensation. Healthy Extracts has been focusing on expanding its product offerings and market presence, particularly through its recent acquisition of Gummy USA, which was finalized in October 2025. This acquisition is expected to enhance revenue growth and gross profit margins by adding contract manufacturing and formulation services to its portfolio.
In terms of operational metrics, Healthy Extracts has been actively working to increase its customer base and product adoption rates. The company has not disclosed specific customer counts or engagement metrics in its filing, but it has indicated plans to expand its product portfolio to include new health supplements targeting gut health, hydration, and weight management. The overall nutraceutical market is projected to grow at a compound annual growth rate of 7.7%, reaching $1.1 trillion by 2033, which presents significant opportunities for Healthy Extracts.
Despite the positive revenue trajectory, the company faces substantial liquidity challenges, with cash reserves of only $146,935 as of December 31, 2025. The company has accumulated a net loss of over $20 million since its inception, raising concerns about its ability to continue as a going concern. Management has indicated that future operations will depend on raising additional capital and achieving significant operating revenues. The company is exploring various financing options, including the sale of common stock, but acknowledges the risks associated with securing such funding.
Looking ahead, Healthy Extracts aims to leverage its recent acquisitions and expand its market presence through strategic product launches and enhanced marketing efforts. However, the company remains cautious about the competitive landscape and the need to maintain brand reputation amidst increasing competition in the nutraceutical sector. The management's outlook emphasizes the importance of innovation and customer engagement to drive future growth and profitability.
About HEALTHY EXTRACTS INC.
Healthy Extracts Inc. develops and markets plant-based nutraceuticals focused on heart, brain, and immune health. Its proprietary products include citrus bergamot extracts and neuro-formulations, targeting the growing global wellness market. The company leverages innovative delivery systems like gel-pack formats and strategic licensing agreements. Operating primarily in the U.S., it emphasizes natural, high-margin products aimed at consumers seeking preventive health solutions.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.